{"id":25146,"date":"2021-01-27T07:10:53","date_gmt":"2021-01-27T07:10:53","guid":{"rendered":"https:\/\/igcz.poznan.pl\/?page_id=25146"},"modified":"2025-08-06T12:44:44","modified_gmt":"2025-08-06T12:44:44","slug":"eu-projects","status":"publish","type":"page","link":"https:\/\/igcz.poznan.pl\/en\/eu-projects\/","title":{"rendered":"Projects co-funded by the European Union"},"content":{"rendered":"\n

Project title: Development of an innovative therapy for gut dysbiosis \u2014 a unique combination of microbiota, its metabolites, and adaptogens.<\/strong><\/p>\n

Implementation period: 01.01.2025 \u2013 31.03.2026<\/p>\n

EU funding: PLN 3,461,691.85<\/p>\n

Objective: To develop an innovative yet universal oral therapeutic blend that stimulates the healing of dysbiosis and restores homeostasis. Existing clinical trials indicate a significant role of specific plant-derived substances and bacterial metabolic products, particularly short-chain fatty acids (SCFAs), in the treatment of inflammatory bowel diseases. However, these compounds have not been sufficiently characterized in terms of recommended doses and treatment protocols, nor have they been tested in combinations that could be administered to patients to effectively stimulate the colonization of the gut mucosa by commensal microbes. The unique character of the therapy will lie in supplementing the gut microenvironment with the dose and composition necessary for the optimal growth of probiotic bacteria.<\/p>\n

#EUFunds #EuropeanFunds<\/p>\n

\n

Project title: CARDIOPRINT – Cardiac Advanced Regenerative Design Integrating Organic PRINTing<\/strong><\/p>\n

Implementation period: 01.01.2025 \u2013 31.03.2026<\/p>\n

EU funding: PLN 7,326,856.66<\/p>\n

Objective: To prepare physiologically and anatomically compatible 3D cardiac tissue constructs using bioprinting for regenerative medicine purposes. The constructs will consist of heart cells (cardiomyocytes, fibroblasts, vascular cells) derived from human-induced pluripotent stem cells (hiPSCs) and components of the cardiac extracellular matrix, enabling biomimicry of cardiac tissue properties. The project will focus on: (1) reproducing the anatomy of cardiac tissue within the construct, (2) ensuring its contractile functionality, and (3) physiological compatibility with the human heart.<\/p>\n

#EUFunds #EuropeanFunds<\/p>\n

\n

Project title: Integrative multi-omic platform based on high-resolution mass spectrometry for metabolome and microbiome research with machine learning integration.<\/strong><\/p>\n

Implementation period: 01.01.2025 \u2013 31.12.2026<\/p>\n

EU funding: PLN 6,730,424.66<\/p>\n

Objective: To create an innovative high-throughput bioanalytical platform and develop omics techniques in biomedical, biological, and agricultural research, particularly focused on the microbiota of humans, plants, and the environment.<\/p>\n

Project implemented in consortium with the Institute of Plant Genetics of the Polish Academy of Sciences.<\/p>\n

\n

Project title: ERASMUS+<\/strong><\/p>\n

Implementation period: 2024\u20132026<\/p>\n

EU funding: EUR 38,145<\/p>\n

Objective: Supporting international cooperation of universities and research institutes through conducting part of studies and internships abroad, promoting staff mobility, and providing opportunities for participation in projects in cooperation with foreign partners.<\/p>\n

\n

Project title: ERDERA \u2013 European Rare Diseases Research Alliance<\/strong><\/p>\n

Implementation period: 2024\u20132031<\/p>\n

EU funding: EUR 26,250<\/p>\n

Objective: Developing a comprehensive database, knowledge base, and innovative research services in the field of advanced therapies, funding new research projects, offering training, and translating research results into specific solutions for patients.<\/p>\n

ERDERA is a partnership bringing together over 170 institutions from 37 countries, including leading research institutes, patient organizations, European research infrastructures, pharmaceutical and technology companies, public funding agencies, public and private charities, regulatory authorities, health protection bodies, hospitals, universities, and medical associations.<\/p>\n

\n

Project title: SUSTAINIGHT Horizon Europe\/Researchers\u2019 Night 2023, project no. 101162504<\/strong><\/p>\n

Implementation period: 2024\u20132026<\/p>\n

EU funding: EUR 13,860<\/p>\n

Objective: Innovative promotional activities by presenting to the public in an engaging way what scientists do. Promoting science by inviting the public into research laboratories, participating in experiments, workshops, and educational games.<\/p>\n

Project implemented in cooperation with: Pozna\u0144 University of Technology, Adam Mickiewicz University, Pozna\u0144 University of Economics, Pozna\u0144 University of Life Sciences, Institute of Bioorganic Chemistry of the Polish Academy of Sciences, Pozna\u0144 Supercomputing and Networking Center (PCSS).<\/p>\n

\n

Project title: On the road to excellence in unravelling the (epi)genetic landscape of hematologic neoplasms \u2013 NEXT_LEVEL<\/strong><\/p>\n

Implementation period: 2021\u20132023<\/p>\n

Objective: To enhance the scientific excellence of the partner institutions, with particular emphasis on the Institute of Human Genetics of the Polish Academy of Sciences in the field of hemato-oncology.<\/p>\n

EU funding: EUR 899,525<\/p>\n

Project implemented in consortium with: University of Groningen, University of G\u00f6ttingen, University of Ulm.<\/p>\n

Project website.<\/p>\n

The project received funding from the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement no. 952304.<\/p>\n

Partnership project of the Wielkopolska Voivodeship self-government entitled: Activities related to the prevention\/mitigation of the effects of the COVID-19 epidemic under the Wielkopolska Regional Operational Programme 2014\u20132020.<\/p>\n

Implementation period: 2020\u20132021<\/p>\n

EU funding: PLN 1,079,764<\/p>\n

Objective: To increase the safety of medical services provided by healthcare entities and other organizations in the Wielkopolska region engaged in combating the COVID-19 epidemic.<\/p>\n

Project description: The Institute of Human Genetics of the Polish Academy of Sciences implements a task related to the purchase of equipment and materials necessary to combat the COVID-19 epidemic.<\/p>\n

\n

Project title: PROM. International scholarship exchange of doctoral students and academic staff<\/strong><\/p>\n

Implementation period: 2019\u20132021<\/p>\n

Objective: To create a financial support mechanism for scholarship exchanges aimed at doctoral students and academic staff. The program enables participation in short-term educational activities (lasting from 5 to 30 days) aimed at improving competences and qualifications. The project, implemented under the PROM Programme, contributes to improving the accessibility of international education programs and increases the mobility of staff both in terms of Polish university and research institution representatives going abroad and scholarship recipients coming to Poland, including those from outside the EU.<\/p>\n

EU funding: PLN 388,720<\/p>\n

Project website.<\/p>\n

\n

Project title: Development of the internationalization of the Institute of Human Genetics of the Polish Academy of Sciences by supporting institutional capacity to serve foreign doctoral students and researchers (Acronym: 2INTEGRATe)<\/strong><\/p>\n

Implementation period: 2020\u20132021<\/p>\n

Objective: To strengthen the institutional capacity of the Institute of Human Genetics of the Polish Academy of Sciences by implementing training activities for IGC staff and introducing organizational changes.<\/p>\n

EU funding: PLN 145,048<\/p>\n

Project website.<\/p>\n

\n

Project title: Liquid biopsy \u2013 a tool for detecting \u201ccancer fingerprints\u201d in the peripheral blood of patients with head and neck cancers<\/strong><\/p>\n

Implementation period: 2018\u20132021<\/p>\n

Objective: To develop a product: a diagnostic and predictive test for detecting traces of cancer genetic material in the peripheral blood (\u201cCancerFingerprints\u201d) of patients with head and neck squamous cell carcinomas (HNSCC).<\/p>\n

Outcome of the project: A new medical product, previously unknown on the Polish and international markets. The developed product will find wide application in the economy as a diagnostic tool and as a companion to HNSCC therapy, as well as an element of routine periodic examinations.<\/p>\n

EU funding: PLN 4,143,012.50<\/p>\n

The project is implemented by a consortium comprising:<\/p>\n

Pozna\u0144 University of Medical Sciences
Heliodor \u015awi\u0119cicki Clinical Hospital of the Pozna\u0144 University of Medical Sciences
Institute of Human Genetics of the Polish Academy of Sciences
DNA Research Center Sp. z o.o.<\/p>\n

\n

Project title: Functional analysis of the IGH gene regulatory region in B-cell non-Hodgkin lymphomas under the FIRST-TEAM programme of the Foundation for Polish Science co-financed by the European Union under the European Regional Development Fund.<\/strong><\/p>\n

Implementation period: 2019\u20132021<\/p>\n

EU funding: PLN 1,952,960<\/p>\n

Project description: A characteristic feature of B-cell non-Hodgkin lymphomas is the translocation of oncogenes (e.g., MYC, BCL2) to the regulatory region of the immunoglobulin heavy chain (IGH) gene. The proliferation of many lymphomas depends on the expression of these oncogenes and the signaling pathways of the B-cell receptor (BCR), which is expressed from the second, functional IGH allele. Regulatory elements in the IGH gene have been studied in the development of normal B cells, but their role in cancer cells remains undefined. The project aims to identify and characterize functional elements in the IGH regulatory region and enhancer RNAs (eRNAs) necessary for the growth of B-cell lymphoma cells. Modern methods such as CRISPR\/Cas9 screening, GRO-seq, and chromatin immunoprecipitation will be used. The project is carried out in collaboration with scientists from the Netherlands and the USA.<\/p>\n

\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"

Project title: Development of an innovative therapy for gut dysbiosis \u2014 a unique combination of microbiota, its metabolites, and adaptogens. Implementation period: 01.01.2025 \u2013 31.03.2026 EU funding: PLN 3,461,691.85 Objective: To develop an innovative yet universal oral therapeutic blend that stimulates the healing of dysbiosis and restores homeostasis. Existing clinical trials indicate a significant role […]<\/p>\n","protected":false},"author":103,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/page-fullwidth.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-25146","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nProjects co-funded by the European Union - Institute of Human Genetics Polish Academy of Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/igcz.poznan.pl\/en\/eu-projects\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Projects co-funded by the European Union - Institute of Human Genetics Polish Academy of Sciences\" \/>\n<meta property=\"og:description\" content=\"Project title: Development of an innovative therapy for gut dysbiosis \u2014 a unique combination of microbiota, its metabolites, and adaptogens. Implementation period: 01.01.2025 \u2013 31.03.2026 EU funding: PLN 3,461,691.85 Objective: To develop an innovative yet universal oral therapeutic blend that stimulates the healing of dysbiosis and restores homeostasis. Existing clinical trials indicate a significant role […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/igcz.poznan.pl\/en\/eu-projects\/\" \/>\n<meta property=\"og:site_name\" content=\"Institute of Human Genetics Polish Academy of Sciences\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-06T12:44:44+00:00\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/eu-projects\\\/\",\"url\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/eu-projects\\\/\",\"name\":\"Projects co-funded by the European Union - Institute of Human Genetics Polish Academy of Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/#website\"},\"datePublished\":\"2021-01-27T07:10:53+00:00\",\"dateModified\":\"2025-08-06T12:44:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/eu-projects\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/eu-projects\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/eu-projects\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projects co-funded by the European Union\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/#website\",\"url\":\"https:\\\/\\\/igcz.poznan.pl\\\/\",\"name\":\"Institute of Human Genetics Polish Academy of Sciences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/igcz.poznan.pl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Projects co-funded by the European Union - Institute of Human Genetics Polish Academy of Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/igcz.poznan.pl\/en\/eu-projects\/","og_locale":"en_US","og_type":"article","og_title":"Projects co-funded by the European Union - Institute of Human Genetics Polish Academy of Sciences","og_description":"Project title: Development of an innovative therapy for gut dysbiosis \u2014 a unique combination of microbiota, its metabolites, and adaptogens. Implementation period: 01.01.2025 \u2013 31.03.2026 EU funding: PLN 3,461,691.85 Objective: To develop an innovative yet universal oral therapeutic blend that stimulates the healing of dysbiosis and restores homeostasis. Existing clinical trials indicate a significant role […]","og_url":"https:\/\/igcz.poznan.pl\/en\/eu-projects\/","og_site_name":"Institute of Human Genetics Polish Academy of Sciences","article_modified_time":"2025-08-06T12:44:44+00:00","twitter_misc":{"Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/igcz.poznan.pl\/en\/eu-projects\/","url":"https:\/\/igcz.poznan.pl\/en\/eu-projects\/","name":"Projects co-funded by the European Union - Institute of Human Genetics Polish Academy of Sciences","isPartOf":{"@id":"https:\/\/igcz.poznan.pl\/#website"},"datePublished":"2021-01-27T07:10:53+00:00","dateModified":"2025-08-06T12:44:44+00:00","breadcrumb":{"@id":"https:\/\/igcz.poznan.pl\/en\/eu-projects\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/igcz.poznan.pl\/en\/eu-projects\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/igcz.poznan.pl\/en\/eu-projects\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/igcz.poznan.pl\/en\/"},{"@type":"ListItem","position":2,"name":"Projects co-funded by the European Union"}]},{"@type":"WebSite","@id":"https:\/\/igcz.poznan.pl\/#website","url":"https:\/\/igcz.poznan.pl\/","name":"Institute of Human Genetics Polish Academy of Sciences","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/igcz.poznan.pl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/pages\/25146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/users\/103"}],"replies":[{"embeddable":true,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/comments?post=25146"}],"version-history":[{"count":5,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/pages\/25146\/revisions"}],"predecessor-version":[{"id":25842,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/pages\/25146\/revisions\/25842"}],"wp:attachment":[{"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/media?parent=25146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}